Multicentre investigation of pathogenic bacteria and antibiotic resistance genes in Chinese patients with acute exacerbation of chronic obstructive pulmonary disease

Journal of International Medical Research

Volumn 43, Issue 5, 2015, Pages 699-710

  Ma, Xiuqing ^a   Cui, Junchang ^a   Wang, Jing ^b   Chang, Yan ^c   Fang, Qiuhong ^b   Bai, Changqing ^d   Zhou, Xiumei ^e   Zhou, Hong ^f   Feng, Huasong ^g   Wang, Ying ^c   Zhao, Weiguo ^h   Wen, Zhongguang ⁱ   Wang, Ping ^j   Liu, Yi ^k   Yu, Ling ^a   Li, Chunsun ^a   Chen, Liangan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c General Hospital of the Second Artillery   (China)

^d Beijing 307 Hospital   (China)

^e Huaishuling Branch of Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^f BEIJING ELECTRIC POWER HOSPITAL   (China)

^g NAVY GENERAL HOSPITAL   (China)

^h 309TH HOSPITAL OF PLA   (China)

ⁱ 304TH HOSPITAL   (China)

^j 306 HOSPITAL OF PLA   (China)

^k AIR FORCE GENERAL HOSPITAL   (China)

more..

Author keywords

acute exacerbation; antibiotic resistance gene; bacteriology; Chronic obstructive pulmonary disease

Indexed keywords

AMIKACIN; CEFOPERAZONE; LEVOFLOXACIN; LINEZOLID; PENICILLIN DERIVATIVE; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENE AMPLIFICATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIUM; CHINA; CLINICAL TRIAL; DEMOGRAPHY; DISEASE COURSE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIA; BEIJING; DEMOGRAPHY; DISEASE PROGRESSION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84942068347     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060515587577     Document Type: Article

References (30)

1. C.D.MathersD.Loncar. Projections of global mortalityand burden of disease from 2002 to 2030. PLoS Med2006; 3: e442–e442.
2. M.DecramerW.JanssensM.Miravitlles. Chronic obstructive pulmonary disease. Lancet2012; 379: 1341–1351.
3. N.ZhongC.WangW.Yao. Prevalence of chronic obstructive pulmonary disease in China: a large, population based survey. Am J Respir Crit Care Med2007; 176: 753–760.
4. J.R.HurstJ.A.Wedzicha. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med2009; 7: 40–40.
5. T.A.R.SeemungalG.C.DonaldsonE.A.Paul. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med1998; 157(5 Pt 1): 1418–1422.
6. J.VestboS.S.HurdA.G.Agustí. Globalstrategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med2013; 187: 347–365.
7. I.S.PatelT.A.SeemungalM.Wilks. Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations. Thorax2002; 57: 759–764.
8. S.SethiK.MuscarellaN.Evans. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest2000; 118: 1557–1565.
9. S.SethiN.EvansB.Grant. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med2002; 347: 465–471.
10. S.SethiT.F.Murphy. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Micro boil Rev2001; 14: 336–363.
11. S.SethiT.F.Murphy. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med2008; 359: 2355–2365.
12. S.H.LinP.H.KuoP.R.Hsueh. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology2007; 12: 81–87.
13. F.W.KoT.K.NgT.S.Li. Sputum bacteriology in patients with acute exacerbations of COPD in HongKong. Respir Med2005; 99: 454–460.
14. D.StolzM.Christ-CrainR.Bingisser. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest2007; 131: 9–19.
15. C.LlorA.MoragasS.Hernández. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med2012; 186: 716–723.
16. B.R.CelliW.MacNee. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J2004; 23: 932–946.
17. A.BhowmikT.A.R.SeemungalR.J.Sapsford. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax1998; 53: 953–956.
18. M.M.TunneyE.R.KlemA.A.Fodor. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax2011; 66: 579–584.
19. National Committee for Clinical Laboratory Standards. National Committee for Clinical Laboratory Standards, Wayne, Pa. Performance standards for antimicrobial susceptibility testing. 2004, M100–S14. Available at http://www.asm.org/ccLibraryFiles/FILENAME/000000002484/Manual%20of%20Antimicrobial%20Susceptibility%20Testing.pdf
20. F.YeL.X.HeB.Q.Cai. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chin Med J (Engl)2013; 126: 2207–2214.
21. F.W.KoM.IpP.K.Chan. A1-yearprospectivestudyof the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest2007; 131: 44–52.
22. A.PapiC.M.BellettatoF.Braccioni. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med2006; 173: 1114–1121.
23. D.S.HuiM.IpT.Ling. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis. Respirology2011; 16: 532–539.
24. J.EllerA.EdeT.Schaberg. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest1998; 113: 1542–1548.
25. N.SolerA.TorresS.Ewig. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med1998; 157(5 Pt 1): 1498–1505.
26. A.DomenechC.PuigS.Martí. Infectious etiology of acute exacerbations in severe COPD patients. J Infect2013; 67: 516–523.
27. H.WangM.ChenY.Ni. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003–2008. Int J Antimicrob Agents2010; 35: 227–234.
28. A.Y.PelegD.C.Hooper. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med2010; 362: 1804–1813.
29. H.LiY.F.LuoB.J.Williams. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol2012; 302: 63–68.
30. Y.JiangZ.ZhouY.Qian. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother2008; 61: 1003–1006.